Target intelligence / Profile preview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 24 (MTND4P24)

Target
MTND4P24
Molecular classification
Other (Pseudogene)
01

Overview

MT-ND4 pseudogene 24 (MTND4P24) is classified as a pseudogene, specifically a nuclear pseudogene related to the mitochondrial gene MT-ND4, which normally encodes a subunit of complex I (NADH:ubiquinone oxidoreductase) of the mitochondrial electron transport chain[2][4][6][8][10]. The pseudogene is located on the X chromosome and is non-functional; it does not produce a protein product and exhibits multiple mutations, including premature stop codons, that prevent it from encoding a functional enzyme[9][2][4][10]. MTND4P24 is not a therapeutic target, nor is it involved in established biological pathways or disease mechanisms itself. It is named after, but distinct from, the functional mitochondrial ND4 gene, which is well studied in contexts such as mitochondrial disorders and electron transport[1][3][5][7]. However, pseudogenes like MTND4P24 can sometimes complicate genomic studies or PCR amplification by yielding non-functional copies in nuclear DNA[9]. There is no evidence linking MTND4P24 to any drug interactions, clinical biomarkers, or safety concerns[2][4][6][8][10]. Note: If you were seeking information on the functional mitochondrial gene (MT-ND4) rather than the pseudogene, that is a critical distinction. The functional MT-ND4 gene encodes a core subunit of complex I and is relevant for mitochondrial energy metabolism and several diseases, but MTND4P24 is a non-functional pseudogene and is not a therapeutic target[2][4][6][8][10].

Other names
MTND4P24MT-ND4 pseudogene 24

Beyond the preview

Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 24 (MTND4P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 24 (MTND4P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call